Related Experiment Video
Updated: Jul 10, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
DLC-1:a Rho GTPase-activating protein and tumour suppressor
Marian E Durkin1, Bao-Zhu Yuan, Xiaoling Zhou
1Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Abstract:
The deleted in liver cancer 1 (DLC-1) gene encodes a GTPase activating protein that acts as a negative regulator of the Rho family of small GTPases. Rho proteins transduce signals that influence cell morphology and physiology, and their aberrant up-regulation is a key factor in the neoplastic process, including metastasis. Since its discovery, compelling evidence has accumulated that demonstrates a role for DLC-1 as a bona fide tumour suppressor gene in different types of human cancer. Loss of DLC-1 expression mediated by genetic and epigenetic mechanisms has been associated with the development of many human cancers, and restoration of DLC-1 expression inhibited the growth of tumour cells in vivo and in vitro. Two closely related genes, DLC-2 and DLC-3, may also be tumour suppressors. This review presents the current status of progress in understanding the biological functions of DLC-1 and its relatives and their roles in neoplasia.
Insights
The deleted in liver cancer 1 (DLC-1) gene acts as a tumor suppressor. Loss of DLC-1 expression promotes cancer development, while restoring it inhibits tumor growth, highlighting its therapeutic potential.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The deleted in liver cancer 1 (DLC-1) gene encodes a GTPase activating protein regulating Rho GTPases.
- Aberrant Rho protein signaling is implicated in cancer development and metastasis.
- DLC-1 is recognized as a tumor suppressor gene in various human cancers.
Purpose of the Study:
- To review the biological functions of DLC-1 and its related genes (DLC-2, DLC-3).
- To summarize the evidence supporting DLC-1's role as a tumor suppressor.
- To discuss the involvement of DLC-1 and its relatives in neoplasia.
Main Methods:
- Literature review of studies on DLC-1, DLC-2, and DLC-3.
- Analysis of genetic and epigenetic mechanisms affecting DLC-1 expression.
- Evaluation of in vitro and in vivo studies on DLC-1 function.
Main Results:
- Loss of DLC-1 expression is linked to human cancer development.
- Restoration of DLC-1 expression inhibits tumor cell growth.
- DLC-1, DLC-2, and DLC-3 show potential as tumor suppressors.
Conclusions:
- DLC-1 plays a critical role in suppressing tumor formation.
- Understanding DLC-1's function is crucial for cancer research and therapy.
- Related genes DLC-2 and DLC-3 may also possess tumor-suppressive properties.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Activation and Inactivation of G Proteins
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Amplifying Signals via Enzymatic Cascade
